博落回急性及亚慢性毒性试验

博落回对小鼠经口急性毒性和对大鼠腹腔注射慢性毒性试验结果表明：博落回生物碱硫酸盐对昆明系小鼠的急性毒性为：水溶液ＬＤ５０＝９００ｍｇ·ｋｇ＾－１，水混悬液ＬＤ５０＝１０４３ｍｇ·ｋｇ＾－１，均属低毒级。博落回注射液对Ｗｉｓｔａｒ大鼠亚慢性毒作用的靶器官主要为肝，长时间或大剂量接毒引起肝细胞变性，增生，使雄性动物肝／体比明显增高，而血清谷－丙转氯酶下降。     

双低菜籽粕对草鱼和鲤甲状腺、肝、肾组织结构的影响

以组织学方法,研究了投喂不同含量双低菜籽粕对草鱼和鲤甲状腺、肝、肾组织的影响。结果表明:在试验的前28 d,双低菜籽粕各不同含量的日粮(17%、34%、51%、68%)对草鱼甲状腺、肝脏组织没有影响,但菜籽粕含量为68%的试验组草鱼肾小管上皮出现颗粒变性。第42天后,菜籽粕含量为68%的试验组草鱼甲状腺滤泡上皮轻度增生,滤泡结构不规则;菜籽粕含量等于或大于51%的试验组草鱼肝脏出现颗粒变性和空泡变性,肾小球有透明变性,肾脏轻度淤血。在试验的第28天,双低菜籽粕含量等于或大于52.2%的试验组鲤甲状腺滤泡上皮细胞的高度增加,肝细胞空泡变性,有轻微的肾小球透明变性。第42天后菜籽粕含量等于或大于34.8%的试验组鲤甲状腺滤泡上皮细胞的高度增加,滤泡胶质的边缘出现缺刻;肝脏出现淤血,部分肝细胞坏死;肾小球透明变性,肾脏淤血。     

不同植物油对大规格吉富罗非鱼生长性能、组织脂肪酸组成的影响

本试验旨在探究大规格吉富罗非鱼(GIFT)对不同植物油的利用效果,筛选出大规格吉富罗非鱼饲料中合适的植物脂肪源。分别以大豆油(SO)、棕榈油(PO)、棉籽油(CO)、菜籽油(RO)、磷脂油(SL)和大豆油∶棕榈油∶棉籽油∶菜籽油∶磷脂油=1∶1∶1∶1∶1的混合油(MIX)为脂肪源配制6种等氮等脂的试验饲料,饲喂初始体重为(229.92±0.31)g的吉富罗非鱼8周。每种试验饲料投喂4个网箱(重复),每个网箱放养50尾。结果表明:对于增重率和特定生长率,棉籽油组和混合油组显著低于菜籽油组(P0.05)。菜籽油组饲料系数显著低于混合油组(P0.05),其他各组间无显著差异(P0.05)。混合油组蛋白质效率显著低于菜籽油组和磷脂油组(P0.05)。混合油组肝体指数显著高于棕榈油组和菜籽油组(P0.05)。大豆油组、菜籽油组、棕榈油组和磷脂油组在增重率、特定生长率和饲料系数方面没有显著差异(P0.05)。大豆油组和菜籽油组肌肉饱和脂肪酸总量显著低于其他各组(P0.05)。对于肌肉中n-3系脂肪酸/n-6系脂肪酸,菜籽油组显著高于其他各组(P0.05),棉籽油显著低于其他各组(P0.05)。棉籽油组肝脏饱和脂肪酸总量显著高于其他各组(P0.05),菜籽油组则显著低于其他各组(P0.05);对于肝脏n-3/n-6,菜籽油组显著高于其他各组(P0.05)。各组肌肉脂肪酸组成与饲料脂肪酸组成的相关系数均高于肝脏脂肪酸组成与饲料脂肪酸组成的相关系数。在饲料脂肪酸组成与肌肉或肝脏脂肪酸组成的相关系数中,均以棕榈油组最大,磷脂油组最小。由此得出,大豆油、棕榈油、菜籽油和磷脂油可以作为大规格吉富罗非鱼(体重为230~790 g)饲料中良好的脂肪源。大规格吉富罗非鱼肌肉中脂肪酸组成一定程度上被饲料脂肪酸组成影响,但肝脏脂肪酸组成与饲料脂肪酸组成的相关性较小。     

Histopathology of Hematopoietic Tissue in Channel Catfish,Ictalurus punctatus,with Anemia

Outbreaks of anemia (CCA) in channel catfish, Ictalurirs punctatus, in Mississippi occur predominantly during spring and fall. Between October, 1990 and May, 1991, twenty-seven cases of CCA were submitted to the Mississippi Cooperative Extension Service-College of Veterinary Medicine Fish Diagnostic Laboratories. Histologic lesions were identified in the head and trunk kidneys of all affected fish. The head kidney contained less than 25% immature hematopoietic tissue in 3 of 22 cases (14%). 25-50% immature hematopoietic tissue in 7 of 22 cases (32%), and greater than 50% immature hematopoietic tissue in 12 of 22 cases (54%). The trunk kidney contained less than 25% immature hematopoietic tissue in 5 of 27 cases (18%), 25-50% immature hematopoietic tissue in 15 of 27 cases (56%), and greater than 50% immature hematopoietic tissue in 7 of 27 cases (26%). The histopathologic findings noted in cases of CCA from Mississippi affect primarily the hematopietic tissues of the head and trunk kidneys.     

An Abattoir Survey on the Frequency of Fatty Liver Syndrome in Dairy Cows from the Suburbs of Tehran

One hundred and six Holstein and Holstein x native cows were inspected before and after slaughter, and liver samples were taken. The fat content of all the liver samples was estimated by an extraction method (Soxhlet). The livers of 29 cows (27%) were classified as fatty. Seventeen of the animals were newly calved, 47 were non-pregnant, 33 were pregnant and 9 were dry, the median values for the fat content of their livers being 60.6, 34.4, 34.7 and 33.8 mg/g, respectively. The median concentration of liver fat in the first group was significantly different from that in each of the other groups (p < 0.01).     

Fumonisin B1 Metabolism by Bovine Liver Microsomes

Only limited and contrasting information is available about the metabolic fate in cattle of fumonisin B₁, a mycotoxin produced by moulds of Fusarium. This study was carried out to evaluate the hepatic metabolism of fumonisin B₁ by bovine liver microsomes. No biodegradation or metabolization of the mycotoxin by liver microsomes was detectable after incubating fumonisin B₁ with bovine microsomes in the presence of a regenerating system for 1 h. No aminopolyol 1, aminopolyol 2 or aminopentol, metabolites of fumonisin B₁, were detected in any of the incubated samples. The tolerance of ruminants to fumonisin B₁ is apparently not dependent on its detoxification in the rumen.     

Metabolism of flupyrazofos in the isolated perfused rat liver

To investigate the hepatic metabolism of the new insecticide flupyrazofos [O,O-diethyl O-(1-phenyl-3-trifluoromethylpyrazol-5-yl) phosphorothioate], isolated rat liver was perfused with flupyrazofos under single-pass conditions. In outflow perfusate and bile, 1-phenyl-3-trifluoromethyl-5-hydroxyprazole (PTMHP), PTMHP-sulfate and PTMHP-glucuronide conjugates were identified as the metabolites of flupyrazofos. However, O,O-diethyl O-(1-phenyl-3-trifluoromethylpyrazol-5-yl) phosphate (flupyrazofos oxon) was not detected. A HPLC method with UV detection was used to investigate the hepatic disposition of flupyrazofos and its metabolite PTMHP. The concentrations of flupyrazofos, PTMHP and PTMHP conjugates in outflow perfusate reached steady-state levels within 20 min after commencing perfusion of 7.3 microM flupyrazofos. At steady state, the mean extraction ratio of flupyrazofos was 0.93 (+/- 0.01) and clearance was 26.1 (+/- 0.2) ml min-1 which nearly approached perfusate flow rate (28 ml min-1). PTMHP accounted for 55.7 (+/- 5.8)% of eliminated flupyrazofos and was recovered as unchanged PTMHP, PTMHP-sulfate and PTMHP-glucuronide in the bile as well as the outflow perfusate.     

CONTRAST-ENHANCED ULTRASONOGRAPHY IN NORMAL CANINE LIVER. EVALUATION OF IMAGING AND SAFETY PARAMETERS

Contrast-enhanced ultrasonography, a new imaging modality in veterinary medicine, can provide data on tissue perfusion. The objective of this study was to use the ultrasonographic contrast agent SonoVue to evaluate various transit time indices in the normal canine liver, to examine the effect of anesthesia on these parameters, and to evaluate the safety of this agent in dogs. The liver of 11 healthy dogs was studied by ultrasound during an intravenous bolus injection of SonoVue. Each dog underwent the examination twice, first with and later without the use of anesthesia. A time-intensity curve was generated from a selected region of interest within the liver from each scanning session. Ratios derived from peak enhancement, time to peak enhancement, up-slope and full-width half-maximum (FWHM) of the curve were calculated from the time-intensity curves, and are reported. There were no statistically significant differences (P > 0.05) in peak enhancement, up-slope and FWHM between dogs that were anesthetized and dogs that were not. Time to peak enhancement, however, was significantly shorter when the dogs were anesthetized than when they were nonanesthetized (P < 0.05). There were no biologically significant changes in clinical laboratory findings. This study indicates that contrast-enhanced ultrasound using SonoVue gives reproducible liver perfusion data, and appears to be a safe and well-tolerated agent for use in dogs. When considering normal values, the use of anesthetic drugs has to be considered.     

Butylated hydroxyanisole promotes expression of neural specific genes in mouse fetal liver cells through extracellular signal-regulated kinase signaling pathways

AIM: To study the mechanism of butylated hydroxyanisole-induced neural differentiation of fetal liver Sca-1+ cells in vitro. METHODS: Sca-1+ cells from 14.5-day-old mouse fetal liver were isolated with a magnetic cell sorting kit. Cultured cells pretreated with or without extracellular signal-regulated kinase (MEK1) inhibitor, PD98059, were induced by 200 μmol/L butylated hydroxyanisole (BHA) for 24 hours, and then incubated in serum-free medium. Expression of genes in treated or untreated cells were assayed by Western blotting and RT-PCR. RESULTS: There was low level of neuronfilament-L (NF-L) and brain factor-1 (BF-1) in fetal liver Sca-1+ cells, but no neuronfilament-H (NF-H) and tyrosine hydroxylase (TH) was observed. BHA significantly promoted the expression of neuron-specific NF-L, NF-H, BF-1, and TH in fetal liver Sca-1+ cells. NF-L, NF-H, BF-1 and TH increased by 6.32 fold, 2.73 fold, 3.37 fold and 2.68 fold, respectively (all P<0.01 vs untreated cells). However, the expression of BHA-induced genes were inhibited by ERK kinase inhibitor PD98059 (25 μmol/L). CONCLUSION: BHA induces neural differentiation of fetal liver cells through ERK.